問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberD3466C00001
Active

2021-10-01 - 2028-07-07

Phase III

Recruiting8

ICD-10N00.0

Acute nephritic syndrome with minor glomerular abnormality

ICD-10N00.1

Acute nephritic syndrome with focal and segmental glomerular lesions

ICD-10N00.2

Acute nephritic syndrome with diffuse membranous glomerulonephritis

ICD-10N00.3

Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis

ICD-10N00.4

Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis

ICD-10N00.5

Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis

ICD-10N00.6

Acute nephritic syndrome with dense deposit disease

ICD-10N00.7

Acute nephritic syndrome with diffuse crescentic glomerulonephritis

ICD-9580.0

Acute glomerulonephritis, with lesion of proliferative glomerulonephritis

  • Trial Applicant

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator Wei-Sheng Chen 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chang-Fu Kuo Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator WEN-NAN HUANG Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 鄭添財 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yu-Sheng Chang Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Joung-Liang Lan 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 陳相成 風濕免疫科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 吳建陞 Division of Rheumatology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    12 participants

  • Global

    360 participants